ArticleNature communications2026

Gemcitabine plus selinexor in selective advanced sarcomas: a phase I of the Spanish group for research on sarcoma study.

Javier Martin-Broto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.